Biotechnology
Group at a Glance
- 27 members
- 23 members have doctorate or medical degrees
- Members' backgrounds include: Biochemistry, Bioengineering, Biology, Epidemiology, Genetics, Medical Biophysics, Neuroscience, Oncology, Physical Chemistry, Psychobiology, and Toxicology
What Matters to Our Clients
Client Base
We measure our value on a simple metric: our clients stay with us for many years. Often remaining with us after being acquired, they like the fact that we have a remarkable degree of stability among our people. Our clients can rely on the consistency of a solid team to keep pace with their growth.
Working with world leaders in industry and academia, we also represent start-ups and non-profits in the biotech and life sciences space. Our experienced understanding of the issues at stake means that we bring realistic solutions to the table.
Team Approach
Efficient and cost-effective client service is a core firm value. In our Biotechnology Group, that value means working with our Chemical & Materials Technologies Group and our Pharmaceutical Group when their specialized expertise will benefit a client’s project. Our teams routinely include support from our paralegal group and our International Filing Department to contain costs and deliver value.
Technical Depth and Breadth
When it comes to advanced scientific degrees, we field the largest biotechnology group in New England. Aggressively recruiting people who are closest to advancing technology, we quickly grasp the nuances of complex biotechnology matters.
Our clients appreciate the easy way we communicate with their inventors and scientists on the fine distinctions of a particular innovation, and with their business executives on issues that impact the future commercial value of their technology.
The services we provide include: IP strategic planning; patent and trademark acquisition and enforcement; studies on patentability, infringement, and validity; IP audits and due diligence; licensing and technology transfer; interferences; and competitor analysis.
Areas of Expertise
Examples of our group's areas of expertise include:
- Detection systems
- Data mining and analysis
- Diagnostic assays
- Molecular modeling
- Pattern recognition
- Cloning & transgenic technologies
- Gene discovery
- Gene therapy
- Pharmacogenomics
- Population genetics
- Proteomics
- Quantitative genetics
- Allergy
- Arthritis
- Bone & mineral diseases
- Cancer
- Cardiovascular
- Dermatology
- Developmental biology
- Diabetes
- Endocrinology, metabolism & lipids
- Gastroenterology
- Hematology
- Immunology
- Infectious disease
- Neurology
- Obstetrics & gynecology
- Ophthalmology
- Orthopedics
- Psychiatry
- Pulmonary
- Renal
- Rheumatology
- Tissue engineering
- Toxicology
- Transplantation
- Vaccines
- Bacteriology
- Mycology
- Parasitology
- Probiotics
- Virology
- Computational neuroscience
- Neuroanatomy
- Neurodegenerative diseases
- Neurophysiology
- Phychobiology
- Psychopharmacology
- Nucleic acids
- Polysaccharides
- Proteins
- Computational biology
- Synthetic biology
- Ablynx
- Biogen Idec
- Boston Children's Hospital
- Boston College
- Brown University
- Dana Farber Cancer Institute
- Dyax Corporation
- Epizyme, Inc.
- GlaxoSmithKline
- GTC Biotherapeutics, Inc.
- Jackson Laboratory
- Lantheus Medical Imaging
- Ludwig Institute for Cancer Research
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- PathoGenetix
- Progenics Pharmaceuticals Inc.
- Selecta Biosciences, Inc.
- Shire Pharmaceuticals
- Synta Pharmaceuticals, Inc.
- University of Florida Research Foundation, Inc.
- University of Massachusetts
- University of South Florida
- University of Vermont
- Yale University
April 24, 2013 - WOLF GREENFIELD WEBINAR: Key Patent Litigation Decisions and the ITC as Alternate Forum - Replay Now Available
April 2013 - Wolf Greenfield Tops the Boston Business Journal’s List of Largest Area Intellectual Property Law Firms
April 10, 2013 - Wolf Greenfield Patent Attorneys Co-Author Amicus Brief on Behalf of Boston Patent Law Association
April 10, 2013 - Rob Walat quoted in Mass High Tech
March 22, 2013 - Ed Walsh quoted on "first-inventor-to-file" changes
March 22, 2013 - Patrick Waller quoted on the "First-Inventor-to File" system
March 11, 2013 - Patrick Waller quoted in Law360 on first-to-file patent system
March 2013 - Top Actions to Consider in Light of the Biosimilar Act
February 21, 2013 - Wolf Greenfield Attorney Recognized for Pro Bono Service by Women’s Bar Foundation
February 12, 2013 - Deadline approaches for patent protections
February 5, 2013 - Wolf Greenfield Named Elite Trademark Law Firm in World Trademark Report 1000
January 29, 2013 - Preparing for the “First Inventor to File” Transition
January 18, 2013 - Ed Walsh was quoted in a Law360 article on Patent Reform
October 22, 2012 - Fifteen Wolf Greenfield Lawyers Highlighted in 2012 Massachusetts Super Lawyers List
October 18, 2012 - WOLF GREENFIELD SEMINAR: What You Need to Know to Prepare for the "First Inventor to File" Transition - Replay Now Available
September 19, 2012 - Eleven Wolf Greenfield Attorneys Selected for 2013 Best Lawyers in America®
September 6, 2012 - Federal Circuit Establishes New Standard on Divided Infringement and Inducement
July 27, 2012 - Chelsea Loughran quoted in Law360 on the new First-To-File rules
July 13, 2012 - Jenny Chen spoke at the BioTaiwan 2012 conference
June 2012 - Wolf Greenfield Named to IAM 1000 World’s Leading Patent Practitioners List
June 2012 - GBLS Recognizes Wolf Greenfield with 2012 Associates Drive Award
In Re Hyon (5/24/12) - Federal Circuit Clarifies Substantial Evidence Standard on Appeal for Questions of Motivation to Combine
In re MSTG, Inc (4/9/12) - No Settlement Negotiations Privilege
Aventis Pharma v. Hospira (4/9/12) - Federal Circuit Finds Inequitable Conduct For Failure To Cite Prior Art Under the Heightened Therasense Standard
AFT Trust. v. J&L Fiber (4/3/12) - Prosecution History Can Be Used During Claim Construction
March 26, 2012 - IP ALERT - Supreme Court Invalidates Process Claims in Prometheus
Marine Polymer v. HemCon (decided 3/15/12) - Intervening Rights Cannot Be Triggered by Argument Alone in Reexaminations
In re Erik P. Staats and Robin P. Lash (3/5/2012) - Federal Circuit Rejects Restrictions on Broadening Claims in Reissue Applications
ClearValue v Pearl River Polymers (2/17/12) - A Range With No Special Features Can Anticipate Sub-range
In re Google, Inc. (decided 2/6/12) - Substance of Emails Determines Attorney-Client Privilege Protection
January 31, 2012 - Navigating Patent Eligibility for Process Claims
December 2011 - Neil Ferraro Named 2012 Boston Patent Law Association President
January 3, 2012 - Wolf Greenfield Welcomes 2012 Promoting Seven Lawyers to New Positions
November 2011 - America Invents Act: The Implications of Patent Reform
October 12, 2011 - Wolf Greenfield Sponsored MIT Forum Event on October 12
In re Stepan (decided 10/5/11) - BPAI Triggers “New Ground of Rejection” When Changing Statutory Basis of Rejection
September 2011 - America Invents Act – Patent Reform is Finally Here
September 9, 2011 - IP ALERT—Senate Endorses The Long-Awaited Patent Reform
Markem-Imaje Corp. v. Zipher Ltd (decided 9/9/11) - Same Claim Terms Can Have Different Meanings Within Different Limitations
September 8, 2011 - Janice Vatland Was a Panelist at BioForward’s 2011 Bioscience Vision Summit
Classen v. Biogen Idec (decided 8/31/11) - Process Claims With Physical Implementation Steps May Be Patent-Eligible
AIA Engineering v Magotteaux (decided 8/31/11) - Federal Circuit Muddies Reissue Application Practice
August 30, 2011 - Patricia Granahan Named To Martindale-Hubbell® Bar Register of Preeminent Women Lawyers™
August 16, 2011 - National Institutes of Health Intervenes to End Patent Infringement Suit Against The Jackson Laboratory Concerning Mouse Models for Alzheimer’s Research
July 2011 - IP ALERT—Federal Circuit Clears Nucleic Acid Claims But Muddies Waters on Diagnostic Method Claims in Myriad Decision
August 9, 2011 - Patricia Granahan Named to Arrive Magazine’s List of Top Women Lawyers
March 2011 - The Patentability of Stem Cells: A Look at the UK and US Situations
February 25, 2011 - Managing the Pace of Patent Applications
February 17, 2011 - WOLF GREENFIELD SEMINAR: Managing IP Risks: The Importance of Obtaining Freedom to Operate Guidance - presentation now available
January 7, 2011 - Janice Vatland to present at MassBio on the Biologics Price Competition and Innovation (BPCI) Act
January 1, 2011 - Wolf Greenfield filed 2,749 patent applications and 688 trademark applications in 2010.
December 2010 - Wolf Greenfield was ranked #1 in number of patents filed and number of patent attorneys in Mass High Tech’s annual survey
December 17, 2010 - Implementing the BPCI Act: Many Challenges for the FDA
November - Wolf Greenfield sponsored the 11th Annual HBS Health Industry Alumni Conference
November 2010 - Be prepared for biosimilars
October 2010 - iPS Cell Patent Snapshot
August 22, 2010 - Hunter Baker, Ed Gates and Chelsea Loughran presented at the American Chemical Society’s Fall National Meeting
August 20, 2010 - BBJ survey ranks Wolf Greenfield #1 in patent attorneys, patents filed and patents obtained
July 2010 - Risks of False Marking: Reducing Your Exposure
June 2010 - Bilski ruling from US Supreme Court
July 2, 2010 - Industry Groups, Practitioners React To High Court Decision on Method Patents
July 7, 2010 - A Wolf Greenfield Webinar: Forecasting the Future of Method Patents Post-Bilski — archived replay of webinar now available
June 28, 2010 - CLIENT ALERT— Supreme Court Leaves Door Open to Business Method Patents
June 17, 2010 - WOLF GREENFIELD SEMINAR: Strategically Building and Monetizing a Patent Portfolio - replay now available
June 2, 2010 - Wolf Greenfield’s litigation team secured summary judgment of no patent infringement for our client The Jackson Laboratory
April 16, 2010 - Patent Applications Must Have Separate Written Description
April 14, 2010 - CLIENT ALERT— Federal Circuit Decision Reaffirms Separate Written Description Requirement
April 2, 2010 - Practitioners See Little Change From Ariad Decision, Caution Inventors on When to File
April 2, 2010 - CLIENT ALERT— The New Biosimilar Pathway: Biologics Price Competition and Innovation Act
March 31, 2010 - Gene Patent Ruling Could Shake Up Biotech
March 31, 2010 - Look, You Wanna Invent? You'd Better WRITE IT DOWN
February 26, 2010 - Wolf Greenfield wins key claim construction ruling for The Jackson Laboratory
February 19, 2010 - More Organizations Ask PTO to Recalculate Term Adjustments
January 2010 - Michael Siekman interviewed by IP Lawcast
January 13, 2010 - CLIENT ALERT— Federal Circuit Affirms Decision Finding USPTO Miscalculates Patent Term Adjustment
November 18, 2009 - WOLF GREENFIELD SEMINAR: Biotechnology Patent Drafting: New Strategies for New Times- replay now available
October 15, 2009 - CLIENT ALERT — USPTO Rescinds Controversial Rules Restricting Patent Applications
October 2009 - Court Case on Patent Delays Holds Appeal for Industry
October 10, 2009 - Federal Circuit Confirms Diagnostic and Therapeutic Methods Can be Patentable Subject Matter
September 25, 2009 - Lack of timing awareness can mean missed revenue
September 24, 2009 - CLIENT ALERT — Federal Circuit Confirms Diagnostic and Therapeutic Methods Can be Patentable Subject Matter
May 14, 2009 - Our clients Cambridge NanoTech and E Ink named winners of SBANE’s New England Innovation Awards, and our client Formulatrix named as finalist
April 10, 2009 - Gilead's Hypertension Drug Darusentan Will Likely Receive Patent
March 25, 2009 - CLIENT ALERT — Federal Circuit Decision on Controversial PTO Rules
February 2009 - Maximizing Intellectual Property Value in Tough Economic Times- Seminar replay now available
November 12, 2008 - Navigating Technology Collaborations and Joint Ventures—Wolf Greenfield seminar
August 2008 - Wolf Greenfield wins three more years of patent protection for Shire Pharmaceuticals' ELAPRASE treatment
June 6, 2008 - Biotech, IT Stalemate Puts Breaks on IP Reform Law
June, 2008 - Stem Cell Gold Rush
April 11, 2008 - "Patent Issues & Potential Problems" – Invention to Venture Conference / University of Vermont
February 7, 2008 - An Entrepreneur's Guide to the Intellectual Property Galaxy
January 9, 2008 - Wolf Greenfield, Boston, Names Two New Shareholders - Boston Intellectual Property Law Firm Promotes Teja, Trevisan
August 8, 2007 - Wolf Greenfield Names Van Amsterdam to Head Biotech Law Practice
March 29, 2007 - Wolf Greenfield Client Diomed Holdings Wins $12.5 Million Award in Patent Case - Jury Finds Two Defendants Infringed Patent for Varicose Vein Treatment
March 21, 2007 - Wolf Greenfield Names Oyer President and Managing Partner - Lawyer/Scientist Takes Reins at Boston Intellectual Property Law Firm
March 2007 - Can a Biological Sequence be Copyrighted?
January 9, 2007 - Supreme Court Rules in MedImmune Biotech Patent Case; Expert Lawyer Can Comment
January 2, 2007 - Supreme Court Throws Patent Owners a Curveball
November 2006 - Accelerated Examination of Patent Applications: Too Good To Be True?
June 23, 2006 - CLIENT ALERT — Supreme Court Dismisses Case Involving Patentability of Natural Phenomena
June 22, 2006 - Supreme Court Dismisses Case Involving Patentability of Natural Phenomena
Q&A Booklet - Q&A on Patents
Q&A Booklet - Q&A on Intellectual Property Litigation
Q&A Booklet - Q&A on Licensing and Transactions
